Investor profile for ARCH Venture Partners: stage-based planning range, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.
Venture Capital Tracker logo
Venture Capital Tracker

VC fund profile · evidence-aware directory data

ARCH Venture Partners stages, portfolio and investment profile

Chicago-based life-sciences specialist that co-founds and funds seed through growth-stage biotech and deep-science companies, often originating companies directly from academic research.

Keep track of ARCH Venture Partners

Save this profile to your VCT watchlist for a quick return.

View watchlist

Stage-based planning range

$1M–$10M

This is a planning range inferred from stage coverage, not a firm-disclosed check size.

Methodology: Stage bucket inferred from the rounds a fund leads or invests in.

No firm-specific check-size disclosure is recorded.

Source link not recorded Confidence: 25% Verified: Not recorded View methodology

Investment stages

Leads: Seed, Series A

Participates: Seed, Series A, Series B+

Sector focus

Biotech & Life Sciences

Geography

Chicago, IL

Founded 1986

Fund size / AUM

Not recorded

A separate fund-size evidence record is not yet available.

Portfolio in our directory

13

Linked startup profiles

Latest fund vehicle

Not recorded

Vehicle name, size, and vintage are not yet structured.

Recent tracked investment

Happy Health

Series A (reported) / cumulative $75M (BI caveat) · $75M · August 2026

Rounds they lead

Seed Series A

Rounds they invest

Seed Series A Series B+

Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

Portfolio companies we track

Startups in our directory that list ARCH Venture Partners as an investor (13 total).

Related investment articles

Jul 24, 2026

a16z Portfolio Companies on Fire in 2026: AI, American Dynamism & More

Aug 18, 2026

Happy Health's $75M: ARCH Backs At-Home Sleep Apnea Diagnosis via Smart Ring

May 29, 2026

Human Archive's $8.2M Seed: India's Gig Economy Trains the Robots

May 26, 2026

Newark Venture Partners Co-Leads Human Archive $8.2M Seed

May 20, 2026

Exa Labs $250M Series C at $2.2B — a16z-Led AI Search Infrastructure

Feb 15, 2026

645 Ventures Leads Arbor $6.3M Seed for AI Enterprise Research

FAQs about ARCH Venture Partners

Stage fit, check size, thesis, and how founders typically approach this firm — based on public sources and our directory.

ARCH leads Seed and Series A rounds and participates in Series B+ for capital-intensive biotech platforms. The firm frequently originates companies at concept stage, before traditional VC criteria are met.
ARCH check sizes are deal-specific and not published as a single range. Public reporting describes flexibility from small incubation checks to very large platform financings; founders should discuss capital needs against scientific milestones.
Headquartered in Chicago, IL, with additional U.S. offices (e.g., Seattle). ARCH invests in U.S. and international biotech but is deeply tied to major research ecosystems and company-formation hubs.
ARCH focuses on biotechnology and life sciences — drug discovery, diagnostics, and platform biotech — with a mission to catalyze discoveries that prevent, detect, and cure disease.
ARCH commonly leads seed and Series A rounds, especially in companies it co-founds. It is known as a company-builder partner, not a passive follower.
In our directory: Maze Therapeutics (/startup/maze-therapeutics), Ollin Bio (/startup/ollin-bio), ROME Therapeutics (/startup/rome-therapeutics), Gate Bio (/startup/gate-bio), Orbital Therapeutics (/startup/orbital-therapeutics), Curie.Bio (/startup/curiebio).
ARCH engages scientists and entrepreneurs with transformative research — often via university spinout networks and scientific advisors. Warm introductions from academic collaborators or existing ARCH founders are the typical path; use archventure.com for firm context.
No dedicated ARCH article in our blog yet. See the fund profile at /fund/arch-venture-partners and linked biotech startup pages.
Website

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.